BT
NVO

Banque Transatlantique’s Novo Nordisk NVO Stock Holding History

Banque Transatlantique’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$284K Buy
7,982
+7,037
+745% +$333K 0.01% 233
2025
Q4 		$48.1K Sell
945
-1,410
-60% -$72.1K ﹤0.01% 163
2025
Q3 		$131K Sell
2,355
-3,399
-59% -$199K ﹤0.01% 135
2025
Q2 		$398K Buy
5,754
+2,924
+103% +$199K 0.01% 95
2025
Q1 		$195K Sell
2,830
-1,980
-41% -$164K 0.01% 116
2024
Q4 		$411K Buy
+4,810
New +$520K 0.01% 99

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Banque Transatlantique's NVO Position: Q1 2026 in Review

Banque Transatlantique increased its Novo Nordisk (NVO) stake by 745% in Q1 2026, buying an estimated $333K and bringing the position to 7,982 shares worth $284K. The position accounts for 0.01% of the portfolio, ranked #233.

Banque Transatlantique first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. The position peaked at $411K in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Banque Transatlantique held 7,982 shares of Novo Nordisk worth $284K as of Q1 2026.
  • Banque Transatlantique bought 7,037 Novo Nordisk shares in Q1 2026, an estimated $333K.
  • Novo Nordisk made up 0.01% of Banque Transatlantique's portfolio in Q1 2026, its #233 holding.
  • Banque Transatlantique first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • Banque Transatlantique's Novo Nordisk position peaked at $411K in Q4 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Banque Transatlantique's 13F filing for Q1 2026, filed 13 May 2026.